4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001415889-24-023390
CEO AND PRESIDENT bought 14,815 shares at an average $5.09 ($75,359)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szela Mary T CEO AND PRESIDENT | 2024-09-12 | Purchase | +7,520 | $5.20 | $39,104 | 377,382 | D |
| Szela Mary T CEO AND PRESIDENT | 2024-09-13 | Purchase | +1,295 | $4.83 | $6,255 | 378,677 | D |
| Szela Mary T CEO AND PRESIDENT | 2024-09-13 | Purchase | +6,000 | $5.00 | $30,000 | 384,677 | D |
| Open-market purchases · 14,815 sh · avg $5.09 · $75,359 | |||||||
Loading xslF345X05/form4-09132024_090910.xml…